Beijing Centergate Technologies (Holding) Co., Ltd. engages in the development, management and investment of real estate. It operates business through five business segments-biomedical, personal care products, elderly care services, real estate & construction and other business. It mainly engages in the biomedical product preparation including tablets, injections, APIs, capsule, oral solution, granules, narcotic drugs, personal care products, manufacture and sale of commercial concrete and cement products. The firm also engages in the research and development of psychotropic drugs manufacturing and sales and real estate management and development. The company was founded on June 8, 1999 and is headquartered in Beijing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company